Pharmaceutical company stops Viagra for women


Pharmaceutical company stops development of "Viagra for women" after negative evaluation of the US drug FDA.

The “pleasure pill” (flibanserin) for women was surprisingly stopped by the US drug agency FDA. For years, intensive research has been carried out to offer the drug on the German market: Now the pharmaceutical company "Boehringe" has stopped the pharmaceutical development of "Viagra for women". However, the company remains convinced of the active ingredient.

The active ingredient "flibanserin" was actually developed to relieve depression. During development, the researchers at the pharmaceutical company discovered that the substance can also increase the sensation of pleasure in women. Thus, the drug should be sold as "pink Viagra" in pharmacies in order to increase libido especially for women before the menopause. However, due to the negative evaluation of the US drug regulatory agency FDA, the pharmaceutical company "Boehringer Ingelheim" has now stopped researching the "pleasure pill".

The application for approval of flibanserin 100 mg for the treatment of "premenopausal women with Hypoactive Sexual Desire Disorder (HSDD)" was rejected by the American drug agency in the summer as the pill was not effective enough to prevent possible side effects such as e.g. Justify dizziness and fatigue, according to the FDA experts. The agency requested further studies from the pharmaceutical manufacturer. However, the company does not want to share the scope of the required studies. For this reason, the development of the preparation was stopped, as was announced. The development of the pill is now on hold. "The decision was not an easy one," said a company spokesman. However, the company is still convinced of the drug, as it was said.

Side effects were common in studies. These included dizziness, tiredness and nausea. Insomnia, dry mouth, constipation and stress were also occasionally observed as a side effect. In addition, the clinical studies showed that the sedative effect of the substance could also increase the risk of accidents and injuries. It has also been observed that the birth control pill or alcohol, for example, can increase the side effects.

In phase III, the active ingredient "flibanserin" was tested in a total of seven studies. In the two most important studies, statistically better results compared to placebo in terms of sexual satisfaction could be determined, but no significant increase in sexual desire could be demonstrated. (sb, 10/10/2010)

Also read:
Does Viagra make you hard of hearing?
Roche cancer drug trial extended

Image: knipser5 / pixelio.de

Author and source information



Video: How does female Viagra work and who is it right for?


Previous Article

No all-clear for cancer risk from aces

Next Article

Essential oils can be dangerous for children